Scott Fields

About the Author Scott Fields

A media and finance professional with four years experience at Australia’s largest business newspaper: As a journalist, I have covered major economic and financial events, in depth and in a timely manner, building strong relationships with senior executive. I am twice the recipient of Citigroup’s Journalism Award for Excellence in Financial Markets coverage. Prior to my current role I held the role of senior editor at a capital markets publication and worked on the bond syndicate desk at a major bank.

GT Advanced: Too Many “What-Ifs” Keep Us On The Sideline, Says UBS

In a research note published today, UBS analyst Stephen Chin maintained a Neutral rating on GT Advanced Technologies (NASDAQ:GTAT) following the company’s second-quarter results, and lowered his price target to …

Janney Capital Markets Reiterates Buy On Vertex Following 2Q14 Revenue Release

In a research report issued yesterday, Janney Capital Markets analyst Kimberly Lee reiterated a Buy rating on Vertex Pharmaceuticals Inc. (VRTX) and gave it a Fair Value Estimate …

William Blair Maintains Buy On Ultimate Software Group Following Solid Revenue And Earnings Report

In a research report issued yesterday, William Blair analyst Justin Furby reiterated coverage on The Ultimate Software Group, Inc. (ULTI) with a Buy rating.

Roth Capital Reduces Black Diamond Price Target To $10 Following 2Q14 Earnings Results

In a report issued yesterday, Roth Capital analyst Dave King affirmed coverage on Black Diamond (BDE) with a Buy rating and reduced his price target to $10 (from $11). …

Roth Capital Maintains Buy on Hudson Ahead Of 2Q14 Earnings

Roth Capital’s analyst Philip Shen today maintained a Buy rating on Hudson Technologies Inc. (HDSN) and sets the target price at $6.

Unclear If AcelRx Can Address Optical Errors For Zalviso Without Clinical Work, Says Canaccord

In a report issued yesterday, Canaccord Genuity analyst John Newman assigned a Hold rating on shares of AcelRx Pharmaceuticals (ACRX) with a price target of $8, following ACRX’s Zalviso …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts